OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Obliterative Bronchiolitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,309 reports · 70 co-occurring drugs

As of the last recalculation, Obliterative Bronchiolitis appears in 1,309 FAERS reports alongside 70 co-occurring drug terms. The strongest observed disproportionality signal is MEPERIDINE HYDROCHLORIDE (PRR 152.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Meperidine Hydrochloride83152.9154.3
Busulfan95103.4104.1
Moxifloxacin6577.177.5
Moxifloxacin Hydrochloride7663.263.5
Sirolimus4149.950.1
Fludarabine Phosphate11149.049.1
Itraconazole2636.136.2
Cyclosporine19733.033.0
Ganciclovir2031.531.6
Mycophenolate Mofetil22431.431.5
Mycophenolate Mofetil Hydrochloride22431.431.4
Ganciclovir Sodium2030.530.6
Anti-Thymocyte Globulin (Rabbit)1529.930.0
Thiotepa1728.728.7
Tacrolimus22527.427.4
Tacrolimus Ointment 0.1%17125.025.0
Tacrolimus Extended-Release Capsules17124.924.9
Micafungin Sodium1324.624.7
Bendamustine Hydrochloride1824.224.3
Oseltamivir1224.224.2
Canakinumab1623.823.8
Melphalan3323.623.7
Basiliximab1723.323.3
Melphalan Hydrochloride3522.822.8
Valganciclovir Hydrochloride Powder,1722.422.5
Alemtuzumab2520.921.0
Obinutuzumab2120.620.6
Imatinib2220.220.2
Anakinra1918.518.5
Valganciclovir2118.018.0
Valganciclovir Hydrochloride2118.018.0
Mycophenilic Acid2317.918.0
Prednisolone17017.117.1
Prednisolone Oral17017.117.1
Prednisolone Oral Solution17017.117.1
Indomethacin1417.017.0
Mycophenolic Acid3316.816.8
Cyclophosphamide Injection, Solution16316.616.6
Cyclophosphamide16316.616.6
Cyclophosphamide For Injection16316.616.6
Voriconazole Injection2216.416.4
Levofloxacin5916.216.3
Levofloxacin In 5% Dextrose5916.216.3
Morphine7015.715.7
Voriconazole2915.515.5
Rituximab17014.514.6
Amphotericin B1012.812.8
Meropenem2311.611.6
Phenytoin1511.611.6
Adalimumab-Aaty3311.311.4
Guaifenesin2111.111.1
Thalidomide2511.011.0
Brentuximab Vedotin710.910.9
Posaconazole Delayed-Release710.210.2
Posaconazole109.99.9
Infliximab1229.79.7
Tenofovir Disoproxil Fumarate Tablets59.29.2
Oseltamivir Phosphate149.29.2
Granisetron Hydrochloride69.29.2
Tobramycin Sulfate79.09.0
Cytarabine318.48.4
Blinatumomab57.67.6
Azacitidine For87.07.0
Morphine Sulfate516.96.9
Tobramycin106.76.7
Tofacitinib736.66.6
Ruxolitinib296.66.6
Azacitidine126.56.5
Nintedanib126.16.1
Abatacept485.75.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.